BRCA2 and pancreatic adenocarcinoma: We also found that germline BRCA2 variants were associated with higher SNV and indel neoantigen loads in pancreatic adenocarcinoma (PAAD, FDR = 2.9 × 10−18, < 1.0 × 10−50).